Vanguard Group Inc. Increases Position in OR Royalties Inc. $OR

Vanguard Group Inc. raised its holdings in shares of OR Royalties Inc. (NYSE:OR) by 2.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 7,847,015 shares of the basic materials company’s stock after buying an additional 167,970 shares during the period. Vanguard Group Inc.’s holdings in OR Royalties were worth $277,965,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of OR. Assetmark Inc. purchased a new stake in OR Royalties in the fourth quarter worth about $36,000. Caitlin John LLC purchased a new stake in OR Royalties in the third quarter worth about $78,000. Eagle Global Advisors LLC purchased a new stake in OR Royalties in the third quarter worth about $206,000. Merit Financial Group LLC purchased a new stake in OR Royalties in the third quarter worth about $215,000. Finally, Flow Traders U.S. LLC purchased a new stake in OR Royalties in the third quarter worth about $217,000. 68.52% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on OR shares. TD Securities reiterated a “hold” rating on shares of OR Royalties in a report on Monday, February 23rd. Wall Street Zen cut shares of OR Royalties from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 11th. Scotiabank increased their price target on shares of OR Royalties from $41.00 to $51.00 and gave the company a “sector perform” rating in a report on Monday, January 26th. Zacks Research cut shares of OR Royalties from a “strong-buy” rating to a “hold” rating in a report on Tuesday, March 31st. Finally, Canadian Imperial Bank of Commerce restated an “outperform” rating on shares of OR Royalties in a report on Wednesday, February 4th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $46.50.

OR Royalties Trading Up 2.6%

Shares of OR stock opened at $38.45 on Friday. OR Royalties Inc. has a 12-month low of $22.40 and a 12-month high of $48.06. The firm’s 50 day moving average is $39.87 and its 200 day moving average is $38.14. The stock has a market capitalization of $7.21 billion, a P/E ratio of 28.69 and a beta of 0.71.

OR Royalties (NYSE:OR) last released its quarterly earnings results on Wednesday, May 6th. The basic materials company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.34 by $0.06. OR Royalties had a net margin of 78.09% and a return on equity of 15.10%. The business had revenue of $102.83 million for the quarter, compared to the consensus estimate of $103.27 million. As a group, equities analysts predict that OR Royalties Inc. will post 1.36 earnings per share for the current year.

OR Royalties Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Tuesday, June 30th will be given a dividend of $0.065 per share. This represents a $0.26 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Tuesday, June 30th. This is a positive change from OR Royalties’s previous quarterly dividend of $0.06. OR Royalties’s payout ratio is 16.42%.

About OR Royalties

OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.

The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.